Anti-Human CD274 Therapeutic Antibody (Durvalumab)

Recombinant monoclonal antibody to CD274. Durvalumab is a human monoclonal antibody that can be potentially used in the treatment of Cancers, non-small cell lung (NSCLC), Solid tumors, bladder, urothelial.
Supplier Creative Biolabs
Product # TAB-417CQ
Pricing Inquiry
Host Human
Target CD274
Species Reactivity Human
Type IgG1, κ
Applications ELISA, IHC, FC, IP, IF, Inhib, FuncS
Storage Store at -20°C for long-term storage. Avoid freeze/thaw cycles.
Feedback